Starcef 400 mg (Cefixime) Capsules

Introduction:

Starcef 400 mg, manufactured by Beacon Pharmaceuticals Ltd and supplied by Orio Pharma, is a powerful broad-spectrum antibiotic specifically designed to treat severe bacterial infections. Containing Cefixime, Starcef 400 mg belongs to the third generation of cephalosporins, which are known for their effectiveness against a wide range of Gram-positive and Gram-negative bacteria. This medication is particularly useful for treating more severe infections, including those of the respiratory and urinary tracts, as well as certain sexually transmitted infections (STIs). Starcef 400 mg offers a robust treatment option for patients requiring high-dose antibiotic therapy.

Manufacturing Excellence of Beacon Pharmaceuticals Ltd.:

Beacon Pharmaceuticals Ltd. is committed to producing high-quality pharmaceutical products that adhere to stringent international standards. The development of Starcef 400 mg reflects Beacon’s dedication to advancing antibiotic treatments through innovative research, rigorous quality control, and adherence to best manufacturing practices. Their focus on safety and efficacy ensures that Starcef 400 mg is a reliable and effective option for managing severe bacterial infections.

Mechanism of Action:

Starcef 400 mg contains Cefixime, a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis. Cefixime binds to penicillin-binding proteins (PBPs) located inside the bacterial cell wall, which interferes with the final stages of peptidoglycan synthesis. This action weakens the bacterial cell wall, leading to cell lysis and ultimately, the death of the bacteria. This mechanism of action makes Starcef 400 mg effective against a wide variety of bacterial pathogens, including those resistant to other antibiotic classes.

Clinical Applications:

Starcef 400 mg is indicated for the treatment of:

• Severe Respiratory Tract Infections: Starcef 400 mg is effective in treating severe respiratory infections such as pneumonia and bronchitis, especially when caused by bacteria resistant to other antibiotics.
• Complicated Urinary Tract Infections (UTIs): Starcef 400 mg is commonly used to treat complicated bacterial infections of the urinary tract, including pyelonephritis.
• Gonorrhea: Starcef 400 mg is effective in treating uncomplicated gonorrhea caused by Neisseria gonorrhoeae, particularly in cases where single-dose treatment is required.
• Acute Otitis Media: Starcef 400 mg is indicated for the treatment of acute otitis media, especially in children who require a higher dose for effective treatment.

Clinical studies and patient experience have shown that Cefixime at this dosage is highly effective in treating these severe infections, providing rapid relief from symptoms and reducing the duration of illness.

Dosage and Administration:

The recommended dosage of Starcef 400 mg is typically one capsule taken once daily. However, the exact dosage and duration of treatment may vary depending on the severity and type of infection. The capsules should be swallowed whole with water, and it is crucial for patients to complete the full course of antibiotics, even if symptoms improve before the medication is finished, to prevent the development of antibiotic-resistant bacteria.

Benefits of Starcef 400 mg:

• High-Dose Broad-Spectrum Antibiotic: Starcef 400 mg is effective against a wide range of bacteria, making it a potent treatment option for severe infections.
• Rapid Symptom Relief: Starcef 400 mg provides quick relief from the symptoms of severe bacterial infections, helping patients recover more quickly.
• Convenient Once-Daily Dosing: The once-daily dosing of Starcef 400 mg ensures ease of use and promotes patient adherence to the treatment regimen.
• Well-Tolerated: Starcef 400 mg is generally well-tolerated, with a favorable safety profile when used according to the prescribed dosage and duration.

Supplier: Orio Pharma

Orio Pharma ensures that Starcef 400 mg is readily available to healthcare providers and patients, offering reliable access to this essential antibiotic treatment. Their commitment to efficient supply and distribution supports effective management of severe bacterial infections, helping to improve patient outcomes.

Conclusion:

Starcef 400 mg (Cefixime) by Beacon Pharmaceuticals Ltd, supplied by Orio Pharma, represents a trusted and effective solution for treating a wide range of severe bacterial infections. This high-dose broad-spectrum antibiotic offers fast and reliable relief from infection symptoms, helping patients recover quickly and preventing complications. By incorporating Starcef 400 mg into their treatment plans, healthcare providers can offer patients a dependable strategy for managing severe bacterial infections, ultimately leading to better health outcomes and reduced risk of antibiotic resistance.